Citation Impact
Citing Papers
Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint
2017 Standout
Multistate and functional protein design using RoseTTAFold sequence space diffusion
2024 StandoutNobel
Buforins: Histone H2A-derived antimicrobial peptides from toad stomach
2008
A retrospective seven‐year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patients
2009
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
Antibiotic resistance: a rundown of a global crisis
2018 Standout
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
2016 Standout
The intracellular mechanism of action on Escherichia coli of BF2-A/C, two analogues of the antimicrobial peptide Buforin 2
2013
Structure, membrane orientation, mechanism, and function of pexiganan — A highly potent antimicrobial peptide designed from magainin
2008
Tethering antimicrobial peptides: Current status and potential challenges
2010
A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus
2007
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Rituximab in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis and systemic lupus erythematosus: past, present and future
2007
B-cell depletion with rituximab in the treatment of autoimmune diseases
2007
The Science of Antibiotic Discovery
2020 Standout
Designing antimicrobial peptides: form follows function
2011 Standout
Amyloidogenic Protein–Membrane Interactions: Mechanistic Insight from Model Systems
2010
Essential Oils in Food Preservation: Mode of Action, Synergies, and Interactions with Food Matrix Components
2012 Standout
Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance
2012
Systemic Lupus Erythematosus
2011 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
The effects of rituximab on immunocompetency in patients with autoimmune disease
2007
B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus
2007
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
Synergistic interaction of eugenol with antibiotics against Gram negative bacteria
2009
Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions
2019
Efficacy and safety of rituximab in moderately‐to‐severely active systemic lupus erythematosus: The randomized, double‐blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
2009
Control of cell selectivity of antimicrobial peptides
2008
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Knowledge-based computational methods for identifying or designing novel, non-homologous antimicrobial peptides
2011
Belimumab: Review of Use in Systemic Lupus Erythematosus
2012
Antifouling Coatings: Recent Developments in the Design of Surfaces That Prevent Fouling by Proteins, Bacteria, and Marine Organisms
2010 Standout
Experimental Induction of Bacterial Resistance to the Antimicrobial Peptide Tachyplesin I and Investigation of the Resistance Mechanisms
2016
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Eugenol—From the Remote Maluku Islands to the International Market Place: A Review of a Remarkable and Versatile Molecule
2012 Standout
Recent Fascinating Aspects of the CuAAC Click Reaction
2020 StandoutNobel
Mobile Genetic Elements Associated with Antimicrobial Resistance
2018 Standout
Customized Reversible Stapling for Selective Delivery of Bioactive Peptides
2022
A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus
2007
Effects of rituximab on resistant SLE disease including lung involvement
2008
Immobilization Reduces the Activity of Surface-Bound Cationic Antimicrobial Peptides with No Influence upon the Activity Spectrum
2008
Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action
2017 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Pyrolytic Depolymerization of Polyolefins Catalysed by Zirconium‐based UiO‐66 Metal–Organic Frameworks
2024 StandoutNobel
Cytochrome c causes pore formation in cardiolipin-containing membranes
2013
Maintaining Biological Activity by Using Triazoles as Disufide Bond Mimetics
2011 StandoutNobel
Pro-Moieties of Antimicrobial Peptide Prodrugs
2015
Computational Evolution of Threonine-Rich β-Hairpin Peptides Mimicking Specificity and Affinity of Antibodies
2019 StandoutNobel
A Coarse-Grained Model for Polyethylene Oxide and Polyethylene Glycol: Conformation and Hydrodynamics
2009
The Role of Antimicrobial Peptides in Preventing Multidrug-Resistant Bacterial Infections and Biofilm Formation
2011
Nanoparticle PEGylation for Imaging and Therapy
2011 Standout
A review of the current use of rituximab in autoimmune diseases
2008
Transforming Polyethylene into Water-Soluble Antifungal Polymers
2023
Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases
2009
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
2017
Large scale ab initio modeling of structurally uncharacterized antimicrobial peptides reveals known and novel folds
2018
Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: a longitudinal analysis of 52 Hispanic patients
2009
Maintaining Biological Activity by Using Triazoles as Disufide Bond Mimetics
2011 StandoutNobel
Works of Y. Imura being referenced
Action mechanism of tachyplesin I and effects of PEGylation
2007
Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system
2006
Magainin 2 in Action: Distinct Modes of Membrane Permeabilization in Living Bacterial and Mammalian Cells
2008
Lacticin Q, a Lactococcal Bacteriocin, Causes High-Level Membrane Permeability in the Absence of Specific Receptors
2008
Membrane Translocation Mechanism of the Antimicrobial Peptide Buforin 2
2004
Peptide-Lipid Huge Toroidal Pore, a New Antimicrobial Mechanism Mediated by a Lactococcal Bacteriocin, Lacticin Q
2009
Interaction of a Magainin−PGLa Hybrid Peptide with Membranes: Insight into the Mechanism of Synergism
2007